tiprankstipranks
AN2 Therapeutics adopts limited duration stockholder rights plan
PremiumThe FlyAN2 Therapeutics adopts limited duration stockholder rights plan
6M ago
AN2 Therapeutics reports Q2 EPS (48c), consensus (59c)
Premium
The Fly
AN2 Therapeutics reports Q2 EPS (48c), consensus (59c)
6M ago
Morning Movers: Iteris skyrockets following take-private agreement
Premium
The Fly
Morning Movers: Iteris skyrockets following take-private agreement
6M ago
AN2 Therapeutics Announces Major Restructuring and Cost-Cutting Measures
PremiumCompany AnnouncementsAN2 Therapeutics Announces Major Restructuring and Cost-Cutting Measures
6M ago
Intuit initiated, Charter downgraded: Wall Street’s top analyst calls
Premium
The Fly
Intuit initiated, Charter downgraded: Wall Street’s top analyst calls
7M ago
AN2 Therapeutics price target lowered to $2 from $7 at Evercore ISI
Premium
The Fly
AN2 Therapeutics price target lowered to $2 from $7 at Evercore ISI
9M ago
ANTX Earnings this Week: How Will it Perform?
PremiumPre-EarningsANTX Earnings this Week: How Will it Perform?
10M ago
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
Premium
The Fly
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
11M ago
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
Premium
The Fly
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100